From PR-USA.NET:

4Life Research™ announced today the
completion of a new preliminary scientific test showing the effect of 4Life
Transfer Factor Tri-Factor® Formula on IgA antibody production.
Participants took 4Life Transfer Factor Tri-Factor Formula for two weeks,
followed by 4Life Transfer Factor RioVida® Tri-Factor Formula for another
two weeks. One hundred percent of participants saw an increase in the
production rate of salivary secretory IgA when compared to a one-week
baseline, with an average increase of 73%.

IgA antibodies, produced by plasma cells, are highly specific proteins used
by the immune system to bind and neutralize foreign invaders. IgA bathes
the surface of the mucous membranes. These y-shaped proteins bind to
invaders, preventing them from attaching and passing through the mucous
lining into the tissues and bloodstream of the body.

The test was conducted by 4Life Chief Executive Officer David Lisonbee;
Chief Scientific Officer Calvin McCausland, Ph.D.; Health Sciences Advisory
Board Member Richard Bennett, Ph.D.; Director of Health Information
Services Brent Vaughan; and Research Scientist Shane Lefler.

"I'm proud to be associated with a company that values scientific research
so highly," commented McCausland. "It's wonderful to provide effective
immune system support products that are also backed up by sound scientific
studies."

"I continue to be amazed at 4Life Transfer Factor's ability to boost and
support the immune system," said Bennett. "This preliminary IgA test
suggests another layer of vital immune system protection that 4Life
Transfer Factor provides."

Read more…